Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The study is designed to determine the safety, tolerability, and pharmacokinetics in healthy
subjects with multiple intravenous administration of the neuroprotectant YC-6 compared to
placebo.